Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1978 May;40(5):541–546. doi: 10.1136/hrt.40.5.541

Leucocyte migration inhibition test in cases of ischaemic heart disease.

R K Sharma, R C Ahuja, O P Tandon, U C Chaturvedi
PMCID: PMC483442  PMID: 656222

Abstract

Cases of ischaemic heart disease have been studied for the cell-mediated immune response against human heart antigen by using the leucocyte migration inhibition test. In 30 cases of acute myocardial infarction, the leucocyte migration inhibition values started increasing from the first week reaching a peak in 3 to 4 weeks and then declining but still above control values 12 months after infarction. The leucocyte migration inhibition values were significantly higher than control values in another 10 patients with late complications of previous infarction and in those patients with acute myocardial infarction who were less than 40 years of age, who had extensive anterior infarction, or who had a past history of angina pectoris. The leucocyte migration inhibition values were negligible in all the 12 patients with stable angina pectoris, but were high in 2 of the 8 with unstable angina and in 3 of the 4 with the intermediate coronary syndrome. The leucocyte migration inhibition values were much higher in patients with complications, which may be the result of cardiac damage by a cell-mediated immune response.

Full text

PDF
541

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer H., Waters T. J., Talano J. V. Antimyocardial antibodies in patients with coronary heart disease. Am Heart J. 1972 May;83(5):612–619. doi: 10.1016/0002-8703(72)90400-0. [DOI] [PubMed] [Google Scholar]
  2. Chaturvedi U. C., Davies J. W., Flewett T. H. Separation and characterization of cardiac antigen proteins. Clin Exp Immunol. 1973 Dec;15(4):613–622. [PMC free article] [PubMed] [Google Scholar]
  3. Chaturvedi U. C., Gupta R. K., Kapoor A. K., Mathur A., Mehrotra R. M. Effect of viral infection on immunological cardiac injury in rats. Indian J Med Res. 1971 Jan;59(1):1–4. [PubMed] [Google Scholar]
  4. Chaturvedi U. C., Gupta R. K., Mehrotra R. M. Antigenicity and immunopathogenicity of the chemical fractions of heart. Indian J Med Res. 1971 Aug;59(8):1237–1244. [PubMed] [Google Scholar]
  5. Chaturvedi U. C., Mathur A., Gupta R. K., Mehrotra R. M. Immunopathological studies in pericardiotomised rats. J Pathol. 1973 Apr;109(4):345–350. doi: 10.1002/path.1711090409. [DOI] [PubMed] [Google Scholar]
  6. Chaturvedi U. C., Mehrotra R. M. Effect of isoprenaline on experimentally produced immunologic cardiac lesions. Indian J Med Sci. 1969 Feb;23(2):83–87. [PubMed] [Google Scholar]
  7. Chaturvedi U. C., Mehrotra R. M. Effect of neonatal thymectomy on experimentally produced immunological cardiac lesions. Nature. 1967 Oct 21;216(5112):267–268. doi: 10.1038/216267a0. [DOI] [PubMed] [Google Scholar]
  8. Chaturvedi U. C., Mehrotra R. M. Experimentally produced immunologic cardiac lesions. Indian J Med Res. 1967 Jan;55(1):21–28. [PubMed] [Google Scholar]
  9. Chaturvedi U. C. Role of autoimmunity in cardiac diseases. Indian J Pathol Bacteriol. 1974 Oct;17(4):199–204. [PubMed] [Google Scholar]
  10. Chaturvedi U. C., Sharma R. K., Mathur A., Ahuja R. C. Migration-inhibition-test on leucocytes from patients of myocardial infarction. Indian J Pathol Microbiol. 1977 Oct;20(4):197–200. [PubMed] [Google Scholar]
  11. DAVIES A. M., GERY I. The role of autoantibodies in heart disease. Am Heart J. 1960 Nov;60:669–674. doi: 10.1016/0002-8703(60)90350-1. [DOI] [PubMed] [Google Scholar]
  12. Das S. K., Cassidy J. T., Petty R. E. The significance of heart-reactive antibodies in heart disease. Chest. 1974 Aug;66(2):179–181. doi: 10.1378/chest.66.2.179. [DOI] [PubMed] [Google Scholar]
  13. Desai D. C., Alexander S. Treatment of severe angina pectoris. Med Clin North Am. 1972 May;56(3):599–609. doi: 10.1016/s0025-7125(16)32373-2. [DOI] [PubMed] [Google Scholar]
  14. Ehrenfeld E. N., Gery I., Davies A. M. Specific antibodies in heart-disease. Lancet. 1961 May 27;1(7187):1138–1141. doi: 10.1016/s0140-6736(61)92066-9. [DOI] [PubMed] [Google Scholar]
  15. Natu S. M., Chaturvedi U. C. Immunopathogenicity of the purified cardiac protein antigens. Indian J Med Res. 1977 Apr;65(4):554–562. [PubMed] [Google Scholar]
  16. Ortiz-Ortiz L., Zamacona G., Garmilla C., Arellano M. T. Migration inhibition test in leukocytes from patients allergic to penicillin. J Immunol. 1974 Sep;113(3):993–997. [PubMed] [Google Scholar]
  17. Sharma S. S., Kumar S., Kunwar K. B., Mehrotra R. M., Chaturvedi U. C., Mitra M. K. Anticardiac antibodies in ischaemic heart disease. J Assoc Physicians India. 1970 Jul;18(7):595–601. [PubMed] [Google Scholar]
  18. Strausz I., Dóbiás G. Autoantibodies reacting with heart muscle tissue in coronary heart disease. J Clin Pathol. 1967 Mar;20(2):161–165. doi: 10.1136/jcp.20.2.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Thompson A., Halbert S. P. The cardiac auto-immune system. 3. Studies on the cytotoxicity of heart antibodies for pulsating rabbit and rat heart cells in tissue culture. Int Arch Allergy Appl Immunol. 1971;40(2):274–286. [PubMed] [Google Scholar]
  20. VAN DER GELD H. ANTI-HEART ANTIBODIES IN THE POSTPERICARDIOTOMY AND THE POSTMYOCARDIAL-INFARCTION SYNDROMES. Lancet. 1964 Sep 19;2(7360):617–621. doi: 10.1016/s0140-6736(64)90512-4. [DOI] [PubMed] [Google Scholar]
  21. Wartenberg J., Brostoff J. Leucocyte migration inhibition by heart extract and liver mitochondria in patients with myocardial infarction. Br Heart J. 1973 Aug;35(8):845–848. doi: 10.1136/hrt.35.8.845. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES